Mitochondrial encephalomyopathies: therapeutic approach.

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• Mitochondrial diseases lack effective cures, necessitating exploration of diverse therapeutic avenues.
• Current treatments are largely palliative, focusing on symptom management and improving patient well-being.

Purpose of the Study:

• To review and categorize current and emerging therapeutic strategies for mitochondrial diseases.
• To discuss the challenges and potential of various treatment modalities, including gene therapy and preventive measures.

Main Methods:

• Review of existing literature on palliative care, metabolite removal, and cofactor administration for mitochondrial disorders.
• Analysis of experimental approaches in gene therapy, including gene shifting, allotopic expression, and gene correction.
• Examination of preventive strategies such as genetic counseling and prenatal diagnosis.

Main Results:

• Palliative therapies include anticonvulsants, endocrine management, and surgical interventions.
• Metabolite removal strategies target lactic acidosis and other toxic byproducts.
• Administration of metabolites, cofactors, and reactive oxygen species scavengers are current therapeutic mainstays.
• Gene therapy approaches show promise but face challenges like heteroplasmy.
• Exercise and physical therapy improve exercise tolerance in mitochondrial myopathies.

Conclusions:

• While cures remain elusive, a range of treatments can manage mitochondrial disease symptoms.
• Gene therapy and preventive strategies hold significant future potential for treating and preventing these disorders.
• Further research is crucial to develop more effective and targeted therapies for mitochondrial dysfunction.